- Israel
- 0544465614
- steven.macwan@gmail.com
Steven Macwan
Born in Israel and residing in Haifa, 43 years old, and a proud father of three children.
- Executive with 11 years of experience as CEO ,Chief Revenue Officer & VP Sales , Business Development
- Directly responsible for secured funding rounds totaling $62 million.
- Attended Harvard Business School - Executive Education Program , Technion ( BSc, MBA)
- Expertise : Sensor Technology , Robotics, Image processing , Mobile APP AI machine learning ,deep learning , medical and surgical procedures
Education
2017
Executive Education Program, Boston
Harvard Business School
20092011
Master’s Degree in BusinessAdministration (MBA)
Technion - Israel Institute of Technology
20012005
Bachelor’s Degree in Molecular Biochemistry (B.Sc)
Technion - Israel Institute of Technology
20232024
AI Engineering , Computer Vision
IBM Certification
Work experience
20232024
CEO
MICROSTEER - Robotic steering system for precision tumor removal surgeries
Funding - Secured NIS 2.5 Million from the Israel Innovation Authority & NGT Fund
- Link - Steven Joins Microsteer Robotics as New
- R&D - Manage multidisciplinary team of 7 engineers,
- Expertise : Robotics, Computer vision , AI & Machine Learning , Sensor Technology , Simulation , Real time SW development, motion planning ,and laser based prototyping
20132023
Chief Revenue Officer
CNOGA MEDICAL LTD
- 2017 - 2020 VP Global sales
- 2015 - 2017 VP Business Development & Shanghai Office
- 2013 - 2015 Business Development & Europe , Asia Sales Director
20062013
Team Leader - Analytical chemistry
Taro Pharmaceuticals
19982001
Combat Engineering Corp
Israeli Defense Forces (IDF)
- Staff Sergeant , Reserve - Bomb Disposal Unit.
- Commanding course , Shooting instructor course
Funding & Investments
2014
Directly responsible for raising $12M
Cnoga Medical
Link - Globes News CNOGA MEDICAL Raised $12Mil
Identified and engaged potential investors - Hong Kong Private Equity Go Capital & Ehud Olmert Consulting
- Preparing a global business plan, market analysis, financial modeling, sales forecasting, budget projections and sales strategy.
- Created investor pitch decks, identified and engaged potential investors
- Oversaw due diligence, negotiated term sheets and company valuation
2017
Directly responsible for raising $50M
Cnoga Medical
Link - Globes News CNOGA MEDICAL Raised $50Mil
Identified and engaged potential investors - BOE
- Negotiated term sheets , company valuation and commercial agreement (Co Development )
- Preparing China focused business plan, market analysis, financial modeling,
- Global sales forecasting, budget projections and sales strategy.
2024
Directly responsible for securing NIS 2.5M
MicroSteer Robotics
20192023
Buyout & Pre IPO
Cnoga Medical
2019 Pre IPO Initial discussion with investment banks, such as JP Morgan and UBS
2022- 2023 Buyout deal with Reliance Group reach to level of SPA . Deal Failed reject by single board member
Business Development - Co Developemnt
Apple , Samsung , Maxim Integrated , Reliance Group Device , Microsoft, Amazon, Qualcomm Ventures , J&J , Edwards Lifesciences , Fresenius , Oppo , Huawei, Humai , Dai-ichi Japan ,Polar
R&D MANAGEMENT
Serving as the CEO of Microsteer, we developed endoscopic add-on robotic steering systems for the removal of early-stage cancerous tumors.Managed a multidisciplinary team of 7 engineers, gaining expertise in robotics, electronics, real-time software development, motion planning, simulation, sensor integration, and machine learning.
Challenge
The entire R&D team was drafted into the military in November 2023, I was forced to take over the entire project on my own, which required me to quickly gain in-depth expertise in every component of the system.
before conducting safe surgery faced 33 different single points of failures that need to overcome , ranging from electromagnetic interference, micro motors mechanic , thermodynamic issues , control , software , and wiring . Despite these challenges, I successfully recruited three highly skilled temporary engineers. Together, we worked relentlessly, day and night, to troubleshoot and resolve these complex technical problems under extreme time pressure.
I personally oversaw and conducted all system tests, including 12 tissue surgeries and 4 animal surgeries, which were essential identifying critical design improvements,
Achievement
we presented the final prototype to a team of 4 top Israeli surgeons. They conducted the surgery using our robotic system, and the procedure was a complete success the first-ever successful use of our robotic system within a live body, which allow us to secure funding of NIS 2.5 Million .
Business Development
Product
Expanding on Cnoga’s core medical technology, we’ve developed modules and system-on-chips (SoCs) for the fitness sector that combine advanced image processing with thermal and bioimpedance signals. Using AI, machine learning, and cloud computing, these solutions can be easily integrated into various form factors like mobile phones, smartwatches, and other wearables
Challenge
Co-developing system-on-chip (SoC) solutions for monitoring physiological parameters in health and sports applications requires transitioning from DSP-based machine learning to a hybrid model, where data is locally pre-processed and further analyzed using deep learning on the cloud in real-time. This shift to a new processor optimized for wearable devices necessitates strategic partnerships with industry-leading companies
Achievements:
Engaged with Apple, Samsung, Qualcomm Ventures, Garmin, and Polar, resulting in Samsung providing a custom phone with camera access for Cnoga technology integration. Explored SoC development with Maxim Integrated, which proposed a co-development project later introduced to Analog Devices for further exploration
Sales Management
Below - TV News Article
- Israel TV News Article about Cnoga Medical
- Workshop attended by distributors from 15 countries arrived to Cnoga Offices
- Italy TV News Use case of Cnoga Products in Italy - Telemedicine & Covid monitoring
-
Interview Prof. Andreas Pfützner
Achievements & Territories
- Increased sales from zero to $5 million in three years
- Europe, China, Brazil India, Australia & NZ, United States, and Japan.
Business Models
- Work closely with 25 strategic distribution partners across worldwide
- B2B - Distributors , Telemedicine companies , Clinics , Pharmacies
- B2C - Direct sales to customers of our non invasive glucose meter
- B2G - Securing contracts worth $45milin government project monitoring over 3 years
Mobile & Web Application
Led the commercialization of an Azure-based AI platform with API and SDK integration, enabling deep learning for non-invasive health monitoring.
Products
- Cnoga Device - Non Invasive sensor
- Mobile & Web APP
- API & SDK Integration
Business Model
- SaaS model with an initial fixed fee
- API fee or pay-per-measurement model for remote/mobile health services
- SDK license fee + initial hardware fixed fee
Achievement
- Implemented a cloud-based SaaS model for Cnoga’s services, targeting B2C ,B2B and B2G use cases.
- Integrated devices and cloud solutions for customers, offering flexibility to connect through APIs or directly to hardware via SDK.
- Enabled telemedicine services for clinics, hospitals, and government projects to remotely monitor patients, especially during COVID-19 and for chronic conditions.
Armed Forces
- NATO’s Explosive Ordnance Disposal Center of Excellence (EOD-COE) collaborated with Cnoga to assess blood parameters and hemodynamic measurements during the deployment of new exoskeleton technologies for military forces
- The Brazilian Army’s Periodic Health Assessment (PHA) serves as a screening tool to evaluate the individual medical readiness of service members.
- The Brazilian Army also utilizes our system to register and conduct health screenings for immigrants at the Brazil-Venezuela border.
China Market
Overview
- Established and managed Cnoga’s wholly-owned subsidiary in Shanghai,
- leading a team of 25 employees across sales, marketing, technical support, and software development.
- Set up a fully-owned assembly site in the Changzhou Medical Park to support production and operations.
- Managed national distributors and 30 sub-distributors at the provincial level to ensure effective product distribution and market penetration.
Product & Business Model
- Diagnostic device combined with a cloud-based patient management platform.
- Primarily B2B and B2G, collaborating with dedicated companies to deploy remote monitoring system projects funded by the Chinese government.
- API fee or SDK Licence fee + HW Cost
Projects
- Stroke Prevention , Beijing - Collaborated with the National Stroke Prevention Center to monitor high-risk patients using the MTX device, aiming to prevent strokes through continuous monitoring and early detection.
- Citizens’ Bio-parameter Screening Project , Hangzhou - Partnered with the government on a project to create reliable health records for residents by monitoring bio-parameters, contributing to a comprehensive and accurate health database.
- Link - BOE and Cnoga
- Link - PR Newswire Cnoga receive marketing approval in China
- Link - News Paper Article China Plus
- Link - Case Study in China Central Blood Bank
Brazil Market
Sales Channels
- State level municipalities ministry of health utility the benefits web Application and non inasicve sensor for gaining insight of entire population either in local community clinics and Pharmacies Health Point.
- same masss population screening was replicated in India in collaboration with Jio-Reliance Group during Covid vaccination and in China , such projects not only generate revenue but also enable use to expand our training set to variues ethnographic population world wide
Product Diagnostic device + Cnoga Cloud Patient management platform
Business Model : Rental fee of HW + Monthly fee payment per measurement
References
Amazon River - Rural Communities
Cnoga Medical collaborated with the Presbyterian Church of Manaus and Universidad Presbyterian Mackenzie to assess non-invasive bio-parameters in the riverine communities of the Rio Negro in the Amazon.
The MTX device helped diagnose anemia in a significant portion of the population, enabling immediate treatment. It also detected bradycardia in two patients, leading to referrals for pacemaker evaluation, and identified cases of hypertension, allowing for control strategies to be implemented.